CARENE PARULAN: Open Payments
NPI 1659996759 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 17 payments from 6 companies in 2025. Trend: 2023 $573 · 2024 $492 · 2025 $529
Food & beverage: $529
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $269 |
| Pulmonx Corporation | 4 | $69 |
| Insmed, Inc. | 2 | $60 |
| GlaxoSmithKline, LLC. | 2 | $54 |
| GENZYME CORPORATION | 2 | $47 |
| Amgen Inc. | 1 | $28 |
Products named: BREZTRI, TEZSPIRE, CHARTIS CATHETER, FASENRA, Arikayce, NUCALA, DUPIXENT, AIRSUPRA.
Industry payments across CA — which companies pay providers there.
